Original title: Winning the lottery and making a huge profit of 470,000? The most expensive new A-share stock has doubled its pre-market share price today. Source: Fast Technology
The friends who won the “Yiqiao Shenzhou” lottery are going to eat meat today. The issue price of the new GEM stock “Yiqiao Shenzhou” was 292.92 yuan, surpassing Stone Technology (271.12 yuan/share) and became the most expensive new stock in the history of A-shares. The Zhongyi signing (500 shares) requires a payment of 146,500 yuan. Based on the average closing increase of 321.11% on the first day of listing of new shares on the ChiNext, the profit of Yiqiao Shenzhou may be as high as 470,000 yuan.
Today, Yiqiao Shenzhou will be officially listed on the Growth Enterprise Market, and the stock price has soared to 600 yuan per share during the pre-market call auction stage (9:15-9:25), which has doubled the issue price.
Before the issuance, the total market value of Yiqiao Shenzhou was 19.92 billion yuan, and the market value during the call auction period had reached 40.8 billion.
Of course, those who can apply for “Yiqiao Shenzhou” are not entry-level investors. First, you need to open the GEM authority. To open the GEM, individual investors must meet two years of A-share trading experience and meet certain asset requirements (the first 20 The average daily assets on the trading day shall not be less than 100,000 yuan).
The issue price of Yiqiao Shenzhou is the highest in the history of A shares.Previously, there were only 6 stocks with an issue price of more than 200 yuan per share. The top three were Stone Technology (271.12 yuan), Foxit Software (238.53 yuan), and Kangxi Nuo-U (209.71 yuan).
The prospectus shows that Yiqiao Shenzhou’s main business includes products such as recombinant proteins, antibodies, genes and culture media, as well as the development of recombinant proteins and antibodies, and biological analysis and testing services.
From 2018 to 2020, Yiqiao Shenzhou’s operating income was 139,227,700 yuan, 180,826,700 yuan, and 159,629,300 yuan, and net profits attributable to shareholders of the parent company were 36,353,500 yuan, 36,410,900 yuan, and 112,767,700 yuan, respectively.
Regarding the net profit increase of 2969.90% in 2020, Yiqiao Shenzhou stated in the prospectus that the new coronavirus pneumonia epidemic will break out globally in 2020, and the market demand for the company’s new coronavirus-related biological reagent products has increased significantly, and the company’s performance this year has increased significantly. .
Investment requires risk, so everyone is cautious to chase higher.
<!–
–>
.
